BR100 Decreased By (-0.73%)
BR30 Decreased By (-0.77%)
KSE100 Decreased By (-0.49%)
KSE30 Decreased By (-0.47%)
BECO 5.77 Increased By ▲ 0.46 (8.66%)
BML 53.00 Increased By ▲ 1.42 (2.75%)
BOP 33.99 Increased By ▲ 0.03 (0.09%)
CNERGY 8.11 Decreased By ▼ -0.20 (-2.41%)
DCL 12.20 Increased By ▲ 0.40 (3.39%)
FCCL 52.83 Decreased By ▼ -0.17 (-0.32%)
FCSC 5.07 Increased By ▲ 0.12 (2.42%)
FFL 17.95 Decreased By ▼ -0.20 (-1.1%)
FNEL 1.29 Decreased By ▼ -0.03 (-2.27%)
HUMNL 10.88 Decreased By ▼ -0.12 (-1.09%)
KEL 8.02 Decreased By ▼ -0.12 (-1.47%)
KOSM 5.52 Decreased By ▼ -0.06 (-1.08%)
MLCF 86.51 Decreased By ▼ -1.37 (-1.56%)
NBP 185.16 Decreased By ▼ -2.53 (-1.35%)
PACE 10.58 Decreased By ▼ -0.23 (-2.13%)
PAEL 39.42 Decreased By ▼ -0.65 (-1.62%)
PIAHCLA 26.22 Decreased By ▼ -0.27 (-1.02%)
PIBTL 16.67 Decreased By ▼ -0.09 (-0.54%)
PPL 228.18 Decreased By ▼ -2.19 (-0.95%)
PRL 34.68 Decreased By ▼ -0.36 (-1.03%)
PTC 65.33 Increased By ▲ 0.82 (1.27%)
SEARL 90.13 Increased By ▲ 0.25 (0.28%)
SSGC 26.60 Decreased By ▼ -0.37 (-1.37%)
TELE 8.28 Decreased By ▼ -0.09 (-1.08%)
THCCL 58.50 Decreased By ▼ -0.58 (-0.98%)
TPLP 8.22 Increased By ▲ 0.04 (0.49%)
TREET 24.53 Decreased By ▼ -0.47 (-1.88%)
TRG 69.71 Decreased By ▼ -0.92 (-1.3%)
WAVES 9.94 Decreased By ▼ -0.07 (-0.7%)
WTL 1.28 Decreased By ▼ -0.01 (-0.78%)
اردو
Android App
Print Edition Dollar to PKR
Budget 2026-27 Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Topic

drugmakers

Novavax expects COVID-19 vaccine supply in Japan well into 2022

Novavax expects COVID-19 vaccine supply in Japan well into 2022

Published 07 May, 2021 06:41pm
  • Takeda Pharmaceutical Co, Japan's biggest drugmaker, is helping bring the vaccine to the domestic market.
  • The Japanese drugmaker plans to make about 250 million doses of the Novavax vaccine in Japan every year and is receiving funding from Japan's Health, Labour and Welfare ministry to ramp up production.
AstraZeneca's lower EU vaccine supply target hinges on factory approval: document

AstraZeneca's lower EU vaccine supply target hinges on factory approval: document

Updated 13 Mar, 2021 09:10pm
  • The Anglo-Swedish drugmaker said on Friday it would try to deliver 30 million doses to the EU by the end of March, down from a contractual obligation of 90 million and a previous pledge made last month to deliver 40 million doses.
  • AstraZeneca said in the document seen by Reuters that it is assuming the Halix factory will get the green light on March 25 and has pencilled in deliveries of nearly 10 million doses for the following week.
S. Africa's Aspen forecasts 16-18pc sales growth for half year ended December

S. Africa's Aspen forecasts 16-18pc sales growth for half year ended December

Published 23 Feb, 2021 09:09pm
  • The company, which could produce Johnson & Johnson's COVID-19 vaccine by end-March, said revenue from continuing operations is expected to grow between 16% and 18% for the six months ended Dec. 31.
  • Aspen, which also manufactures active ingredients used in medicines and helps in packaging and filling of final products, is due to report its financial results for half year ended Dec. 31 on March 11.
India to start COVID-19 vaccine exports as soon as Wednesday

India to start COVID-19 vaccine exports as soon as Wednesday

Published 19 Jan, 2021 06:19pm
  • The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.
  • India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.
Lilly says Alzheimer's drug slows clinical decline in mid-stage trial

Lilly says Alzheimer's drug slows clinical decline in mid-stage trial

Published 11 Jan, 2021 06:51pm
  • The drug is an antibody designed to remove clumps of the Alzheimer's-related protein beta amyloid from the brain.
  • Lilly said the mid-stage trial of 272 patients met its main goal of showing a statistically significant change in clinical decline over 18 months.
European watchdog could decide on AstraZeneca vaccine by end-Jan

European watchdog could decide on AstraZeneca vaccine by end-Jan

Published 08 Jan, 2021 06:38pm
  • The Astrazeneca shot, which was developed with Oxford University, was given a green light by authorities in Britain on Dec. 30.
  • It has so far recommended the Pfizer-BioNtech and Moderna vaccines for European Union approval, which was quickly granted for both.
Bangladesh's Beximco in coronavirus vaccine pact with India's Serum Institute

Bangladesh's Beximco in coronavirus vaccine pact with India's Serum Institute

Published 28 Aug, 2020 04:46pm
  • The deal comes after Bangladesh said this month it was ready to hold trials of candidate vaccines developed by India as both countries seek to curb the spread of the virus.
  • Beximco will also be the exclusive supplier for Bangladesh for a vaccine developed by the Serum Institute, it said.
Loading...